Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGAT1 | O75907 | 16/20 | 0.51 |
| ▸ | SOAT1 | P35610 | 2/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.44 |
| ▸ | ACSL1 | P33121 | 2/20 | 0.43 |
| ▸ | ACACB | O00763 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4598307 | 0.85 | KMT2A (0.48) | DGAT1ACACB | |
| SCHEMBL30356841 | 0.82 | DGAT1 (0.50) | DGAT1SOAT1KCNH2ACSL1 | |
| SCHEMBL1588860 | 0.82 | DGAT1 (0.50) | DGAT1SOAT1KCNH2ACSL1 | |
| SCHEMBL25074385 | 0.82 | DGAT1 (0.50) | DGAT1SOAT1KCNH2ACSL1 | |
| SCHEMBL1588861 | 0.82 | DGAT1 (0.50) | DGAT1SOAT1KCNH2ACSL1 | |
| SCHEMBL25196581 | 0.82 | DGAT1 (0.50) | DGAT1SOAT1KCNH2ACSL1 | |
| SCHEMBL25204122 | 0.79 | DGAT1 (0.50) | DGAT1SOAT1KCNH2ACSL1 | |
| SCHEMBL15152818 | 0.79 | DGAT1 (0.58) | DGAT1SOAT1KCNH2 | |
| SCHEMBL3690947 | 0.79 | DGAT1 (0.50) | DGAT1SOAT1KCNH2ACSL1 | |
| SCHEMBL15152822 | 0.79 | DGAT1 (0.58) | DGAT1SOAT1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070066624-A1 | Chemokine receptor binding compounds | ANORMED, INC. (CA) | 2007-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070066624-A1 | Chemokine receptor binding compounds | CCR5, CCR4, CCR1 | DGAT1 2918/4885SOAT1 3619/4885KCNH2 4762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.